GLORIA WHITE: Open Payments
NPI 1154440964 · GREENFIELD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$932 in 38 payments from 7 companies in 2025. Trend: 2023 $799 · 2024 $479 · 2025 $932
Food & beverage: $795Education: $137
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $318 |
| Otsuka America Pharmaceutical, Inc. | 11 | $232 |
| Vanda Pharmaceuticals Inc. | 14 | $174 |
| Alkermes, Inc. | 3 | $75 |
| Indivior Inc. | 2 | $71 |
| ABBVIE INC. | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
Products named: COBENFY, FANAPT, REXULTI, ARISTADA, SUBLOCADE, ABILIFY ASIMTUFII, VRAYLAR, CAPLYTA.
Industry payments across MA — which companies pay providers there.
